Skip to main content

Advertisement

Log in

Inducible expression of p21WAF-1/CIP-1/SDI-1 from a promoter conversion retroviral vector

  • ORIGINAL ARTICLE
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

 Constitutive, high-level expression of the potentially therapeutic WAF-1/CIP-1/SDI-1 gene is incompatible with cell growth. A promoter conversion retroviral vector carrying the WAF-1/CIP-1/SDI-1 gene under the transcriptional control of the glucocorticoid inducible promoter of mouse mammary tumor virus was used to infect human bladder carcinoma or feline kidney cells. Reduced cell growth due to a greater proportion of cells being in the G0/G1 phase of the cell cycle was observed when WAF-1/CIP-1/SDI-1 expression was activated by addition of glucocorticoid hormone. This system demonstrates the potential long-term therapeutic use of WAF-1/CIP-1/SDI-1 delivered by retroviral vectors for inhibiting the growth of rapidly proliferating cells. Moreover, the conditional expression of genes such as WAF-1/CIP-1/SDI-1 from such retroviral vectors may facilitate analysis of their function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 24 March 1997 / Accepted: 5 July 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mrochen, S., Klein, D., Nikol, S. et al. Inducible expression of p21WAF-1/CIP-1/SDI-1 from a promoter conversion retroviral vector. J Mol Med 75, 820–828 (1997). https://doi.org/10.1007/s001090050171

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001090050171

Navigation